- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
3.6 Diagnosis and Investigations |
79 |
|
|
•Only renal pelvis visualized, dilated pelvis on ultrasonography, no caliectasis
–Grade 2:
•Moderately dilated renal pelvis and a few calyces
–Grade 3:
•Hydronephrosis with nearly all calyces seen, large renal pelvis without parenchymal thinning
–Grade 4:
•Severe dilatation of renal pelvis and calyces with accompanying parenchymal atrophy or thinning
•Approximately 20 % of antenatally diagnosed hydronephroses are not found on postnatal ultrasound.
•PUJ obstruction is known to be associated with other types of congenital abnormality. This is seen in almost 50 % of patients.
•PUJ obstruction is bilateral in about 10 % of patients (Figs. 3.16, 3.17 and 3.18).
•About 10 % of patients with PUJ obstruction have ipsilateral vesicoureteral reflux and to detect this, a voiding cystourethrogram should be part of the work-up of these patients.
•There are also reports of coexisting PUJ obstruction and uretero-vesical junction obstruction. In these cases, the uretero-vesical obstruction is usually mild and PUJ obstruction should be treated first.
•Duplication anomalies usually cause PUJ obstruction at the lower poles and the possibility of vesicoureteral reflux should be rolled out.
•Rarely, the PUJ may be so severe leading to massive dilation of the renal collecting system and these patients may present with a palpable flank mass. This however is a rare and unusual presentation of PUJ at present.
•PUJ obstruction is often associated with other congenital anomalies, including:
–Anorectal malformations
–Contralateral multicystic kidney
–Congenital heart disease
–VATER (vertebra, anus, trachea, esophageal, renal) syndrome
–Esophageal atresia
The SFU Grading System for
Hydronephrosis
•Grade 0:
–No hydronephrosis, intact central renal complex seen on ultrasonography
•Grade 1:
–Only renal pelvis visualized, dilated pelvis on ultrasonography, no caliectasis
•Grade 2:
–Moderately dilated renal pelvis and a few calyces
•Grade 3:
–Hydronephrosis with nearly all calyces seen, large renal pelvis without parenchymal thinning
•Grade 4:
–Severe dilatation of renal pelvis and calyces with accompanying parenchymal atrophy or thinning
3.6Diagnosis and Investigations
•Prenatal evaluation:
–Prenatal ultrasound is widely used to diagnose fetal abnormalities.
–Among these abnormalities is PUJ obstruction.
–Prenatal ultrasound evaluation should include the followings:
•Amniotic fluid volume to rule out oligohydramnios
•Bladder volume
•Kidney size
•Anteroposterior diameter of the renal pelvis
•Other associated abnormalities
–Functionally significant hydronephrosis can be determined when:
•The anteroposterior diameter of the renal pelvis is more than 10 mm.
•The ratio of the renal pelvis to the anteroposterior kidney size is more than 0.3.
•There is evidence of caliectasis after 24 weeks of gestation.
80 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
Figs. 3.16, 3.17, and 3.18 Abdominal CT-scan and intravenous urography showing bilateral hydronephrosis secondary to PUJ obstruction
•Patients with PUJ obstruction diagnosed by prenatal ultrasound should have a postnatal ultrasound. The timing of ultrasound is variable and depends on the severity of the PUJ obstruction.
•In general, however, ultrasound examination should be avoided in the first 2 days after birth, because hydronephrosis may not be detected because of extracellular fluid shifts
that will underestimate the degree of hydronephrosis.
•Therefore, in unilateral disease, ultrasonography should be performed at least after 48 h of life.
•These patients should also be placed on prophylactic antibiotics (amoxicillin 15 mg/kg) to prevent urinary tract infections.
•Other investigations include:
– Complete blood count
3.6 Diagnosis and Investigations |
81 |
|
|
–Urine analysis and culture
–Serum electrolytes, BUN and creatinine
–Plain abdominal radiograph
–Abdominal ultrasound
–Abdominal CT-scan
–Abdominal MRI
–A nuclear renal scan can
–Intravenous urography
–Voiding cystourethrography
–Percutaneous nephrostography
–Cystoscopy and retrograde pyelography
–A Whitaker antegrade pressure-flow study
•Serum electrolytes, BUN and creatinine are important to measure renal function especially in those with bilateral disease.
•Urine analysis and culture are important to roll out associated urinary tract infection especially in asymptomatic patients.
•Abdominal radiograph (Fig. 3.19):
–A plain abdominal x-ray may show a soft tissue density secondary to a hydronephrotic kidney.
Fig. 3.19 Abdominal radiograph showing a soft tissue density on the left side in a child with severe left PUJ obstruction
–A plain abdominal x-ray may also show radiopaque stones complicating PUJ obstruction.
•Abdominal ultrasound (Figs. 3.20 and 3.21):
–Renal ultrasound will show a dilated renal pelvis with a collapsed non-dilated ureter.
–Renal ultrasound is also important to measure the size of the renal pelvis and it is useful for follow-p to monitor changes in the size of the renal pelvis.
–Ultrasound can also help determine the size of the kidney, the size of renal and the thickness of renal parenchyma.
–Ultrasound is also important to detect other associated urological abnormalities.
–Duplex Doppler ultrasonography can be used to assess intrarenal vasculature and determine the resistive index.
•Normal kidneys reliably demonstrate resistive indices less than 0.7, and obstructed kidneys show higher values.
•This is especially reliable in the preoperative diagnosis of aberrant-accessory blood vessels associated with PUJ obstruction.
–Renal ultrasound is a relatively cheap investigation, devoid of radiation and can easily be repeated.
•Intravenous urography (Figs. 3.22, 3.23 and 3.24):
–Historically, intravenous pyelography (IVU) was used to evaluate patients with possible PUJ obstruction.
–The administration of frusemide helps exclude a ‘baggy pelvis’.
–Currently, intravenous urography is replaced by other less invasive and more informative investigations.
–Intravenous urography has the risk of radiation exposure and contrast media including nephrotoxicity and anaphylactic reactions.
•The diagnosis of intermittent UPJ obstruction is confirmed if hydronephrosis is present when the child is symptomatic, and resolves when the child is well. A diuretic renal scan will document baseline renal function and may also provoke symptoms during the diuretic phase of the study, which confirms the diagnosis.
82 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
Figs. 3.20 and 3.21 Andominal ultrasound showing severe hydronephrosis secndary to PUJ obstruction
• Abdominal CT-scan (Figs. 3.25, 3.26, 3.27, |
– In children, this study has several |
|||||
3.28 and 3.29): |
|
advantages: |
|
|
|
|
– Abdominal CT-urography is very useful in |
|
• |
No radiation exposure. |
|
|
|
establishing the severity of PUJ obstruction |
|
• |
Excellent anatomical |
and |
functional |
|
including the renal parenchymal volume. |
|
|
details. |
|
|
|
– Establishing the anatomy of PUJ obstruction. |
|
• |
It provides details of renal vasculature, |
|||
– Identification of an intrinsic cause or high- |
|
|
renal pelvis anatomy, location of cross- |
|||
insertion PUJ. |
|
|
ing vessels, renal cortical thickness and |
|||
– Demonstrating crossing vessels and their |
|
|
scarring. |
|
|
|
relationship to the ureter of the PUJ. |
– |
The disadvantage of this |
investigation is |
|||
– The localization of these vessels and their |
|
that it is not readily available and require |
||||
possible contribution to renal obstruction is |
|
general anesthesia. |
|
|
|
|
important for surgical planning and the |
– Contrast-enhanced magnetic resonance angi- |
|||||
most effective treatment modality. |
|
ography (MRA) was reported to have a sensi- |
||||
– If an endopyelotomy is planned, this infor- |
|
tivity of 85%, a specificity of 80%, and a |
||||
mation can guide the surgeon in directing |
|
positive predictive value of 0.8 for the diagno- |
||||
the endopyelotomy incision away from |
|
sis of aberrant and obstructing renal arteries. |
||||
crossing vessels. |
• Diuretic renography (Fig. 3.32): |
|
|
|||
– It is also useful in outlining the location of |
– A diuretic renal scan should be performed |
|||||
secondary causes of PUJ obstruction includ- |
|
to |
quantify relative renal function and to |
|||
ing aberrant vessels, kinks, and adhesions. |
|
define the extent of obstruction. |
|
|
||
– Spiral (helical) CT-scan is more useful as it |
– |
There are several isotope tracers that are |
||||
provides superior longitudinal resolution. |
|
used for diuretic renography including: |
|
|||
– Abdominal CT-scan requires sedation or |
|
• |
Mercaptotriglycylglycine (MAG-3) |
|
||
general anesthesia in very small children and |
|
• |
Diethylenetriamine (DTPA) |
|
|
|
also carries the risk of radiation exposure. |
|
• |
Dimercaptosuccinic acid (DMSA) |
|
||
– Abdominal CT-scan has a sensitivity of |
|
• |
Technetium-99m-mercaptoacetyltriglycine |
|||
97 %, specificity of 92 %, and accuracy of |
|
|
(99m Tc-MAG3) |
|
|
|
96 % in detecting crossing vessels associ- |
– This is the most noninvasive technique |
|||||
ated with PUJ obstruction. |
|
used to determine the severity and func- |
||||
• Abdominal MRI (Figs. 3.30 and 3.31): |
|
tional significance of PUJ obstruction. |
|
|||
– Dynamic contrast-enhanced magnetic res- |
– The preferred radioisotope is technetium- |
|||||
onance urography (MRU) is the latest |
|
99m-mercaptoacetyltriglycine |
(99m |
Tc- |
||
imaging modality used in assessing PUJ |
|
MAG3), which is taken up by the renal cortex, |
||||
obstruction. |
|
filtered across the glomerular basement mem- |
3.6 Diagnosis and Investigations |
83 |
|
|
Figs. 3.22, 3.23, and 3.24 Intravenous urography showing bilateral PUJ obstruction
brane to the renal tubules, and excreted into the renal pelvis and urinary tract.
–MAG3 is another tracer that is mainly intravascular and secreted by proximal renal tubules, with a small fraction being filtered by the glomeruli.
–Another widely used tracer is technetium 99m diethylenetriamine penta-acetic acid
(99m Tc-DTPA), which, owing to the small size of molecule, diffuses within both intravascular and extravascular spaces, resulting in significant background activity.
–The diuretic renography measures the drainage time from the renal pelvis (referred to as washout) and assesses total and each individual kidney’s renal function.
84 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
Figs. 3.25, 3.26, and 3.27 Abdominal CT-scans showing hydronephrosis secondary to PUJ obstruction (Note the very severe obstruction in the middle picture with
almost complete renal atrophy where there is only a small rim of renal parenchyma remaining while in the lower one the renal parenchyma is still preserved)
Figs. 3.28 and 3.29 Abdominal CT-scan showing bilateral hydronephrosis secondary to PUJ obstruction
3.6 Diagnosis and Investigations |
85 |
|
|
Figs. 3.30 and 3.31 Abdominal MRI showing bilateral hydronephrosis secondary to PUJ obstruction (Note the thickness of the renal parenchyma on the right side. It is thinned out as a result of severe obstruction and back pressure)
Fig. 3.32 A diuretic nephrogram of a child with a left PUJ obstruction
–The washout measurement correlates with the degree of obstruction.
–The patency of the PUJ is determined by measuring the T1/2 (the time required for 50% of the isotope to be excreted) on the wash-out curve. Rapid drainage (low T1/2)
indicates no obstruction, while impaired drainage or slow or no washout (T1/2 >20 min) indicates obstruction.
–Another important measurements in diuretic renography is the estimate of differential renal function. This is considered
86 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
Figs. 3.33 and 3.34 Voiding cystourethrograms in two children with PUJ obstruction (Note the absence of VUR. Note also the soft tissue density on the right side in the lower picture representing the enlarged right kidney)
significant when it is less than 40 %. Diuretic (Furosemide) Renogram is performed to differentiate obstructive from nonobstructive hydronephrosis.
–Sometimes an unusually high differential renal function can be seen on the affected kidney. This is attributed to an increase in single-nephron filtration or nephron volume.
–Currently, a diuretic renal scan is important
to diagnose those with functionally significant PUJ obstruction. The Reno graphic criteria include:
• A flat or rising washout curve after diuretic with T 1/2 of greater than 20 min and differential function of less than 40.
•The differential function is important in determining the need for intervention, especially in asymptomatic patients, and in selecting the appropriate treatment (pyeloplasty vs nephrectomy).
•Poorly functioning kidneys (<10 %) are often best treated with nephrectomy.
–In general, a half-life greater than 20 min to clear the isotope from the kidney is considered indicative of obstruction, although
other urologists use split function, comparing the function of the two kidneys, as a means to identify patients for surgery.
–Renal isotope scan is also used to assess outcomes after surgical correction of PUJ obstruction.
•A voiding cystourethrography (VCUG) (Figs. 3.33 and 3.34):
–A voiding cystourethrography (VCUG) is part of the work up of these patients.
–This is to rule out vesicoureteral reflux.
–Vesicoureteral reflux (VUR) has been found in as many as 40% of children with PUJ obstruction but the reported incidence of VUR in association with PUJ obstruction is about 10%.
–The VUR is usually mild and usually resolve spontaneously.
•Retrograde/antegrade pyelography:
–Retrograde pyelography was used to assess the upper ureter and renal pelvis.
–Retrograde or antegrade pyelography requires general anesthesia.
–It is now mostly performed at the time of surgical correction of the PUJ obstruction to establish the exact site of obstruction.
–A percutaneous nephrograohy (Figs. 3.35, 3.36, 3.37 and 3.38):
3.6 Diagnosis and Investigations |
87 |
|
|
Figs. 3.35, 3.36, 3.37, 3.38, and 3.39 Nephrostograms showing unilateral and bilateral PUJ obstructions. Percutaneous nephrostograms are useful especially in newborns with severe hydronephrosis (Note only they
confirm the diagnosis and severity of PUJ but they are useful for temporary drainage of the obstructed kidney to refive the pressure from the renal parenchyma)
•This can be diagnostic and also used to temporary drain the kidney to decompress the renal pelvis and relive the pressure on the renal parenchyma.
•This is valuable especially in newborns with severe obstruction. The ureter is small in these patients which makes it difficult to reconstruct the PUJ and a temporary nephrostomy will drain the obstructing kidney and buy time.
•Pressure flow studies:
–When the radiological investigations are equivocal, a Whitaker antegrade pressureflow study may be performed to further evaluate for PUJ obstruction.
–This is done as follows:
•A small-diameter nephrostomy tube is inserted percutaneously into the kidney.
•Dilute contrast medium is instilled, and the intrarenal collecting system is pressure-monitored.